United Kingdom· GB-APID-38748011000001102
Doxepin 25mg capsules
A doxepin product containing doxepin, registered in United Kingdom by Crescent Pharma Ltd. The same ATC class is registered in 9 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Doxepin is registered in 9 of 19 countries.
Countries holding a registration under ATC N06AA12 (doxepin), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 6 of them publish a price we can compare per daily dose
Doxepin · ATC N06AA12
9 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Germany
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Doxepin
- Manufacturer
- Crescent Pharma Ltd
- Country
- United Kingdom (GB)
- ATC code
- N06AA12
- ATC class
- Doxepin
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5017123360138
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
932 interactions on record for doxepin.
Graded by severity as the source publishes them — 148 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Doxepin · interactions on record
932 records
- 148 severe
- 527 moderate
- 32 minor
- 148 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
77 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Doxepin in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandDoxepin Rivopharm 25 mg, capsule rigideRivopharm SA
- CanadaSINEQUANAA PHARMA INC
- SpainSINEQUAN 25 MG CÁPSULAS DURASFarmasierra Laboratorios S.L.
- NorwaySinequanOrifarm AS
- PolandDoxepin TevaTeva Pharmaceuticals Polska Sp. z o.o.
- GermanyDoxepin AlAliud Pharma Gmbh
- FranceQUITAXON 10 mg, comprimé pelliculé sécablePROVEPHARM
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Germany · Doxepin Al, Doxepin Ratiopharm
- Spain · Sinequan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d6b4082d-c044-4326-97ae-07d03f121ab9 GET /v1/drugs/d6b4082d-c044-4326-97ae-07d03f121ab9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "38748011000001102",
"desc": "Doxepin 25mg capsules (Crescent Pharma Ltd)",
"form": "Oral capsule",
"vpid": "42270911000001101",
"source": "dmd",
"vtm_id": "775696004",
"strength": "25 mg",
"substance": "Doxepin",
"ingredient": "Doxepin hydrochloride",
"supplier_code": "18616811000001107"
}See everything about doxepin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.